28490631|t|A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells.
28490631|a|Triggering receptor expressed on myeloid cells 2 (TREM2) is a single transmembrane molecule uniquely expressed in microglia. TREM2 mutations are genetically linked to Nasu-Hakola disease and associated with multiple neurodegenerative disorders, including Alzheimer's disease. TREM2 may regulate microglial inflammation and phagocytosis through coupling to the adaptor protein TYRO protein-tyrosine kinase-binding protein (TYROBP). However, there is no functional system for monitoring this protein-protein interaction. We developed a luciferase-based modality for real-time monitoring of TREM2-TYROBP coupling in live cells that utilizes split-luciferase complementation technology based on TREM2 and TYROBP fusion to the C- or N-terminal portion of the Renilla luciferase gene. Transient transfection of human embryonic kidney 293 cells with this reporter vector increased luciferase activity upon stimulation with an anti-TREM2 antibody, which induces their homodimerization. This was confirmed by ELISA-based analysis of the TREM2-TYROBP interaction. Antibody-mediated TREM2 stimulation enhanced spleen tyrosine kinase (SYK) activity and uptake of Staphylococcus aureus in microglial cell line BV-2 in a kinase-dependent manner. Interestingly, the TREM2 T66M mutation significantly enhanced luciferase activity without stimulation, indicating constitutive coupling to TYROBP. Finally, flow cytometry analyses indicated significantly lower surface expression of T66M TREM2 variant than wild type or other TREM2 variants. These results demonstrate that our TREM2 reporter vector is a novel tool for monitoring the TREM2-TYROBP interaction in real time.
28490631	129	134	TREM2	Gene	54209
28490631	150	198	Triggering receptor expressed on myeloid cells 2	Gene	54209
28490631	200	205	TREM2	Gene	54209
28490631	275	280	TREM2	Gene	54209
28490631	317	336	Nasu-Hakola disease	Disease	MESH:C536329
28490631	366	393	neurodegenerative disorders	Disease	MESH:D019636
28490631	405	424	Alzheimer's disease	Disease	MESH:D000544
28490631	426	431	TREM2	Gene	54209
28490631	456	468	inflammation	Disease	MESH:D007249
28490631	526	570	TYRO protein-tyrosine kinase-binding protein	Gene	7305
28490631	572	578	TYROBP	Gene	7305
28490631	738	743	TREM2	Gene	54209
28490631	744	750	TYROBP	Gene	7305
28490631	841	846	TREM2	Gene	54209
28490631	851	857	TYROBP	Gene	7305
28490631	955	960	human	Species	9606
28490631	978	981	293	CellLine	CVCL:0045
28490631	1074	1079	TREM2	Gene	54209
28490631	1178	1183	TREM2	Gene	54209
28490631	1184	1190	TYROBP	Gene	7305
28490631	1222	1227	TREM2	Gene	54209
28490631	1249	1271	spleen tyrosine kinase	Gene	6850
28490631	1273	1276	SYK	Gene	6850
28490631	1301	1322	Staphylococcus aureus	Species	1280
28490631	1347	1351	BV-2	CellLine	CVCL:0182
28490631	1401	1406	TREM2	Gene	54209
28490631	1407	1411	T66M	ProteinMutation	tmVar:p|SUB|T|66|M;HGVS:p.T66M;VariantGroup:0;CorrespondingGene:54209;RS#:201258663;CorrespondingSpecies:9606;CA#:347275
28490631	1521	1527	TYROBP	Gene	7305
28490631	1614	1618	T66M	ProteinMutation	tmVar:p|SUB|T|66|M;HGVS:p.T66M;VariantGroup:0;CorrespondingGene:54209;RS#:201258663;CorrespondingSpecies:9606;CA#:347275
28490631	1619	1624	TREM2	Gene	54209
28490631	1657	1662	TREM2	Gene	54209
28490631	1708	1713	TREM2	Gene	54209
28490631	1765	1770	TREM2	Gene	54209
28490631	1771	1777	TYROBP	Gene	7305
28490631	Association	MESH:C536329	54209
28490631	Association	MESH:D000544	54209
28490631	Association	MESH:D019636	54209
28490631	Positive_Correlation	54209	6850
28490631	Association	MESH:D007249	54209
28490631	Association	54209	7305

